1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Type 1 Diabetes Camps Project: 2025-2027 Campership Initiative is sponsored by New Venture Fund (with funding from The Leona M. and Harry B. Helmsley Charitable Trust and Eli Lilly and Company).
This initiative provides financial support to diabetes camping organizations nationwide, specifically for need-based scholarships ("camperships") for low-income youth with type 1 diabetes (T1D) and their families.
Get alerted about grants like this
Get emailed when new opportunities from “New Venture Fund (with funding from The Leona M. and Harry B. Helmsley Charitable Trust and Eli Lilly and Company)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
New Venture Fund Launching RFP for “The Type 1 Diabetes Camps Project: 2025-2027 Campership Initiative” With Funding From the Helmsley Charitable Trust and Eli Lilly and Company - Helmsley Charitable Trust Helmsley Charitable Trust New Venture Fund Launching RFP for “The Type 1 Diabetes Camps Project: 2025-2027 Campership Initiative” With Funding From the Helmsley Charitable Trust and Eli Lilly and Company The project aims to provide financial support to diabetes camps for need-based scholarships for youth with type 1 diabetes (T1D) and their families.
NEW YORK, N. Y. , September, 6, 2024 – The New Venture Fund (NVF), a public charity that works to achieve a healthier, more equitable world, has launched a request for proposals for the Type 1 Diabetes Camps Project: 2025-2027 Campership Initiative .
This initiative seeks applications from diabetes camping organizations nationwide serving youth living with type 1 diabetes (T1D) and their families. Funding is for supporting need-based full or partial scholarships “camperships” for low-income youth with T1D to attend camp and staff development.
T1D camps provide essential social support to youth with T1D, including the opportunity to learn how to manage diabetes while connecting with peers and others in a safe, fun environment. The initiative is supported by $6 Million in grant funding from The Leona M. and Harry B.
Helmsley Charitable Trust and $900 Thousand in funding from Eli Lilly and Company over the next three years. T1D — an autoimmune disease in which the body is unable to produce insulin — is a lifelong condition that can begin very early in childhood.
Successful management requires frequent monitoring of blood sugar, daily injections of insulin, and decisions around diet, activity, and other factors that can contribute to variations in blood sugar. The complexity of managing the condition can be overwhelming to children and adolescents with diabetes, such that family and community social support are crucial.
The challenges of managing the disease are exacerbated for low-income youth who often have difficulty accessing quality care. “Diabetes camps provide an environment where youth with T1D can have fun safely, find peer-to-peer support, learn new diabetes management tools, and build a community. ” said Deniz Dalton, Program Officer in the Type 1 Diabetes Program at the Helmsley Charitable Trust.
“At Helmsley, we are committed to supporting whole person approaches to care, and to ensuring that all people with T1D and their families can access them. We’re proud to continue to support the camp initiative. ” This new RFP builds upon the 2022-2024 T1D Camps Project, a current NVF project funded by grants from Helmsley and Eli Lilly.
Diabetes camps normalize T1D, create support networks, and promote best practices in medical and self-care. Without these camperships, many would otherwise be unable to attend. NVF-funded camps will also be invited to attend a grantee conference each year so that they can learn from and network with like-minded organizations.
“The T1D Camps Project gives young people the chance to connect and build community as they develop the skills they need to manage their diabetes,” said Lee Bodner, President of New Venture Fund. “NVF exists to ease operational burdens on changemakers, like the leaders of the T1D Camps Project, so that they can focus on furthering their mission and affecting more lives for the better.
We could not be prouder to support the T1D Camps Project as they empower youth living with T1D. ” “Living with diabetes requires daily attention and commitment – often for the whole family – and type 1 diabetes affects individuals of all different genders, ethnicities, and financial backgrounds.
We are proud to expand our partnership with Helmsley to provide inspiration, recognition and education to help people living with diabetes overcome the challenges of the condition, regardless of financial status,” said Sarah Noel, executive director of U.S. Diabetes Advocacy and Professional Relations, Eli Lilly and Company.
For more information about the RFP, please login and navigate to the publicly available RFPs : https://newventurefund. force. com/login The New Venture Fund (NVF) is a 501(c)(3) public charity that supports a wide range of nonpartisan projects aimed at making the world more equitable and fair for everyone.
A leading fiscal sponsor, NVF provides operational support to help advocates and philanthropists quickly and efficiently launch new solutions to today’s toughest challenges, including climate change, youth empowerment and education, and global health and international development. Since its founding in 2006, NVF has helped launch over 500 philanthropic projects. For more information, visit https://newventurefund.
org/ . About The Leona M. and Harry B.
Helmsley Charitable Trust The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional efforts in the U.S. and around the world in health and select place-based initiatives.
Since beginning active grantmaking in 2008, Helmsley has committed more than $4. 5 billion for a wide range of charitable purposes. The Helmsley Type 1 Diabetes (T1D) Program is the largest private foundation funder in the world with a focus on T1D, with more than $1 billion to date committed to transform the trajectory of the disease and to accelerate access to 21st century care, everywhere.
For more information on Helmsley and its programs, visit helmsleytrust. org . New Venture Fund, T1D Initiative, t1dinitiative@newventurefund.
org Caitlin Ford, Helmsley Charitable Trust Communications Associate, cford@helmsleytrust. org NCQA Receives Grant From the Helmsley Charitable Trust to Advance High-Quality Diabetes Care Blue Circle Health Expands Novel Type 1 Diabetes Program to 5 More States ACHP Receives $4. 2M Grant to Improve Diabetes Care and Outcomes from the Helmsley Charitable Trust
According to the current listing, eligibility includes: Diabetes camping organizations nationwide serving youth living with type 1 diabetes (T1D) and their families. Confirm the full requirements in the official notice before applying.
The current listing shows $6 Million (Helmsley Charitable Trust) and $900 Thousand (Eli Lilly and Company) over three years for the initiative. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The Type 1 Diabetes Camps Project: 2025-2027 Campership Initiative is funded by New Venture Fund (with funding from The Leona M. and Harry B. Helmsley Charitable Trust and Eli Lilly and Company). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The Eli Lilly and Company Foundation's 2026 Open Call opened June 1 and closes July 3, across three focus areas: Global Health, K-12 STEM Education, and Economic Mobility. But two of the three only fund Marion County, Indiana. Here is how to read the geographic fine print, why the funder's commercial identity shapes what wins, and how to position a proposal that actually fits.
Read articleThe Economic Development Administration's Build to Scale program is level-funded at $50 million for FY2026 across two competitions — the Venture Challenge and the Capital Challenge. Both require a 1:1 match and reward regional coalitions that spent months building a pipeline before the NOFO dropped. Here's how the program actually works and how to be ready when it opens.
Read articleThe Lilly Foundation's 2026 Open Call accepts pre-applications June 1 through July 3. Its three priorities — Global Health, K-12 STEM Education, and Economic Mobility — look national, but the education and mobility tracks concentrate heavily in Marion County, Indiana, while the health track funds cardiometabolic work abroad. Here's how to read the geography before you spend a week on a pre-application you can't win.
Read article